PCM
INSM icon

Piermont Capital Management’s Insmed INSM Stock Holding History

Piermont Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,220
Closed -$224K – 196
2014
Q2 		$224K Hold
11,220
– – 0.09% 118
2014
Q1 		$214K Buy
+11,220
New +$213K 0.1% 119

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Piermont Capital Management's INSM Position: Q3 2014 in Review

Piermont Capital Management sold out of Insmed (INSM) in Q3 2014, closing a stake of 11,220 shares — an estimated $224K sold.

Piermont Capital Management first reported a position in INSM in Q1 2014 and held it in 2 quarters. The position peaked at $224K in Q2 2014. 102 funds tracked by Wall St. Rank hold INSM as of Q3 2014.

  • Piermont Capital Management reported no remaining Insmed position as of Q3 2014 after selling out during the quarter.
  • Piermont Capital Management sold 11,220 Insmed shares in Q3 2014, an estimated $224K.
  • Piermont Capital Management first reported a position in Insmed in Q1 2014 and held it in 2 quarters.
  • Piermont Capital Management's Insmed position peaked at $224K in Q2 2014.
  • 102 funds tracked by Wall St. Rank held Insmed as of Q3 2014.

Based on Piermont Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.